{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:02:27Z","timestamp":1787166147333,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hacettepe University Scientific Research Coordination Unit","award":["(Project Number: THD-2019-18151)"],"award-info":[{"award-number":["(Project Number: THD-2019-18151)"]}]},{"name":"Hacettepe University Scientific Research Coordination Unit","award":["(Project Number: THD-2019-18151)"],"award-info":[{"award-number":["(Project Number: THD-2019-18151)"]}]},{"name":"Hacettepe University Scientific Research Coordination Unit","award":["(Project Number: THD-2019-18151)"],"award-info":[{"award-number":["(Project Number: THD-2019-18151)"]}]},{"name":"Hacettepe University Scientific Research Coordination Unit","award":["(Project Number: THD-2019-18151)"],"award-info":[{"award-number":["(Project Number: THD-2019-18151)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is characterized by androgen excess and ovulatory dysfunction and appears to be associated with alterations in muscle mass and function. The study aims to investigate whether oral contraceptive (OC) use affects muscle mass and strength in women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Twenty women with PCOS (median age 20.5 years and BMI 26.1\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) and 20 age- and BMI-matched healthy controls were included. Clinical, hormonal, and biochemical assessments were conducted along with body composition analyses using magnetic resonance imaging (MRI) proton density fat fraction (PDFF%) and muscular strength assessment by isokinetic dynamometry. In women with PCOS, measurements were repeated after at least three cycles of OC therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At baseline, women with PCOS exhibited significantly higher levels of total testosterone, free androgen index (FAI), and homeostasis model assessment of insulin resistance (HOMA-IR) levels compared to healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004, respectively). PCOS group also showed significantly higher average power (AvP) of knee extensors at 60\u00b0\/sec (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). AvP correlated positively with total testosterone and FAI levels in the whole study group (r\u2009=\u20090.450,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004, r\u2009=\u20090.318,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.045, respectively). Following OC therapy, testosterone levels and FAI decreased (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively); whereas thigh muscle mass or lower limb strength remained unchanged.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Short-term OC use in women with PCOS led to a reduction in androgen excess without measurable effects on muscle composition or strength. These findings suggest that muscle function and composition remain stable over the short term, despite hormonal modulation. Further research is required to understand how long-term management strategies for PCOS might affect muscle mass and function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-025-04305-9","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:16:25Z","timestamp":1749813385000},"page":"647-654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of oral contraceptive use on muscle mass and strength in women with PCOS"],"prefix":"10.1007","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-9381","authenticated-orcid":false,"given":"Seren","family":"Aksun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-196X","authenticated-orcid":false,"given":"Levend","family":"Kara\u00e7oban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-2404","authenticated-orcid":false,"given":"Ilkay","family":"Idilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-7662","authenticated-orcid":false,"given":"Bulent O.","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"4305_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"R. Azziz, E. Carmina, Z. Chen, A. Dunaif, J.S. Laven, R.S. Legro, D. Lizneva, B. Natterson-Horowtiz, H.J. Teede, B.O. Yildiz, Polycystic ovary syndrome. Nat. Rev. Dis. Prim. 2, 16057 (2016). https:\/\/doi.org\/10.1038\/nrdp.2016.57.","journal-title":"Nat. Rev. Dis. Prim."},{"key":"4305_CR2","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"B.O. Yildiz, G. Bozdag, Z. Yapici, I. Esinler, H. Yarali, Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 27, 3067\u20133073 (2012). https:\/\/doi.org\/10.1093\/humrep\/des232.","journal-title":"Hum. Reprod."},{"key":"4305_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"N. Helvaci, B.O. Yildiz, Polycystic ovary syndrome as a metabolic disease. Nat. Rev. Endocrinol. 21, 230\u2013244 (2025). https:\/\/doi.org\/10.1038\/s41574-024-01057-w.","journal-title":"Nat. Rev. Endocrinol."},{"key":"4305_CR4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/humrep\/der070","volume":"26","author":"JG Dolfing","year":"2011","unstructured":"J.G. Dolfing, C.M. Stassen, P.M. van Haard, B.H. Wolffenbuttel, D.H. Schweitzer, Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS. Hum. Reprod. 26, 1495\u20131500 (2011). https:\/\/doi.org\/10.1093\/humrep\/der070.","journal-title":"Hum. Reprod."},{"key":"4305_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","volume":"16","author":"S Kirchengast","year":"2001","unstructured":"S. Kirchengast, J. Huber, Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum. Reprod. 16, 1255\u20131260 (2001). https:\/\/doi.org\/10.1093\/humrep\/16.6.1255.","journal-title":"Hum. Reprod."},{"key":"4305_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/dmrr.2767","volume":"32","author":"S Gao","year":"2016","unstructured":"S. Gao, Y. Cheng, L. Zhao, Y. Chen, Y. Liu, The relationships of irisin with bone mineral density and body composition in PCOS patients. Diabetes Metab. Res. Rev. 32, 421\u2013428 (2016). https:\/\/doi.org\/10.1002\/dmrr.2767.","journal-title":"Diabetes Metab. Res. Rev."},{"key":"4305_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1055\/s-0032-1309006","volume":"120","author":"FM Mario","year":"2012","unstructured":"F.M. Mario, F. do Amarante, M.K. Toscani, P.M. Spritzer, Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance. Exp. Clin. Endocrinol. Diabetes 120, 511\u2013516 (2012). https:\/\/doi.org\/10.1055\/s-0032-1309006.","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"4305_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/jcm13020483","volume":"13","author":"J Cai","year":"2024","unstructured":"J. Cai, J. Yue, N. Lu, S. Li, J. Zheng, R. Huang, Y. Jiang, C. Shan, W. Liu, J. Ma, L. Wang, Association of fat mass and skeletal muscle mass with cardiometabolic risk varied in distinct PCOS subtypes: a propensity score-matched case-control study. J. Clin. Med. 13, 483 (2024). https:\/\/doi.org\/10.3390\/jcm13020483.","journal-title":"J. Clin. Med."},{"key":"4305_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rbmo.2020.04.024","volume":"41","author":"SH Oguz","year":"2020","unstructured":"S.H. Oguz, I. \u0130dilman, N. Helvaci, E.C. Guzelce, D. Eyupoglu, M. Karcaaltincaba, B.O. Yildiz, Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome. Reprod. Biomed. Online 41, 329\u2013334 (2020). https:\/\/doi.org\/10.1016\/j.rbmo.2020.04.024.","journal-title":"Reprod. Biomed. Online"},{"key":"4305_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0284185115580488","volume":"57","author":"IS Idilman","year":"2016","unstructured":"I.S. Idilman, O. Keskin, A. Celik, B. Savas, A.H. Elhan, R. Idilman, M. Karcaaltincaba, A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol. 57, 271\u2013278 (2016). https:\/\/doi.org\/10.1177\/0284185115580488.","journal-title":"Acta Radiol."},{"key":"4305_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1172\/jci117731","volume":"95","author":"G Biolo","year":"1995","unstructured":"G. Biolo, R.Y. Declan Fleming, R.R. Wolfe, Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J. Clin. Invest. 95, 811\u2013819 (1995). https:\/\/doi.org\/10.1172\/jci117731.","journal-title":"J. Clin. Invest."},{"key":"4305_CR12","doi-asserted-by":"publisher","first-page":"204201882093431","DOI":"10.1177\/2042018820934319","volume":"11","author":"P Kempegowda","year":"2020","unstructured":"P. Kempegowda, E. Melson, K.N. Manolopoulos, W. Arlt, M.W. O\u2019Reilly, Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 11, 2042018820934319 (2020). https:\/\/doi.org\/10.1177\/2042018820934319.","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"4305_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0029-7844(99)00311-7","volume":"94","author":"T Douchi","year":"1999","unstructured":"T. Douchi, S. Yamamoto, T. Oki, K. Maruta, R. Kuwahata, Y. Nagata, Serum androgen levels and muscle mass in women with polycystic ovary syndrome. Obstet. Gynecol. 94, 337\u2013340 (1999). https:\/\/doi.org\/10.1016\/s0029-7844(99)00311-7.","journal-title":"Obstet. Gynecol."},{"key":"4305_CR14","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/s0015-0282(02)02968-0","volume":"77","author":"M Notelovitz","year":"2002","unstructured":"M. Notelovitz, Androgen effects on bone and muscle. Fertil. Steril. 77, S34\u2013S41 (2002). https:\/\/doi.org\/10.1016\/s0015-0282(02)02968-0. Suppl 4.","journal-title":"Fertil. Steril."},{"key":"4305_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2165\/00007256-199621010-00003","volume":"21","author":"NP Gleeson","year":"1996","unstructured":"N.P. Gleeson, T.H. Mercer, The utility of isokinetic dynamometry in the assessment of human muscle function. Sports Med. 21, 18\u201334 (1996). https:\/\/doi.org\/10.2165\/00007256-199621010-00003.","journal-title":"Sports Med."},{"key":"4305_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ijerph18010035","volume":"18","author":"R \u015aliwowski","year":"2020","unstructured":"R. \u015aliwowski, J. Marynowicz, M. Grygorowicz, A. Wieczorek, \u0141 Jadczak, Are there differences in concentric isokinetic strength perfor-mance profiles between international and non-international elite soccer players?. Int. J. Env. Res. Public. Health 18, 35 (2020). https:\/\/doi.org\/10.3390\/ijerph18010035.","journal-title":"Int. J. Env. Res. Public. Health"},{"key":"4305_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jns.2017.03.022","volume":"376","author":"M J\u00f8rgensen","year":"2017","unstructured":"M. J\u00f8rgensen, U. Dalgas, I. Wens, L.G. Hvid, Muscle strength and power in persons with multiple sclerosis - a systematic review and meta-analysis. J. Neurol. Sci. 376, 225\u2013241 (2017). https:\/\/doi.org\/10.1016\/j.jns.2017.03.022.","journal-title":"J. Neurol. Sci."},{"key":"4305_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/obr.12422","volume":"17","author":"J Zibellini","year":"2016","unstructured":"J. Zibellini, R.V. Seimon, C.M. Lee, A.A. Gibson, M.S. Hsu, A. Sainsbury, Effect of diet-induced weight loss on muscle strength in adults with overweight or obesity - a systematic review and meta-analysis of clinical trials. Obes. Rev. 17, 647\u2013663 (2016). https:\/\/doi.org\/10.1111\/obr.12422.","journal-title":"Obes. Rev."},{"key":"4305_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3803\/EnM.2021.958","volume":"36","author":"SH Oguz","year":"2021","unstructured":"S.H. Oguz, B.O. Yildiz, An update on contraception in polycystic ovary syndrome. Endocrinol. Metab. 36, 296\u2013311 (2021). https:\/\/doi.org\/10.3803\/EnM.2021.958.","journal-title":"Endocrinol. Metab."},{"key":"4305_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/humupd\/dmt038","volume":"20","author":"Y Zimmerman","year":"2014","unstructured":"Y. Zimmerman, M.J. Eijkemans, H.J. Coelingh Bennink, M.A. Blankenstein, B.C. Fauser, The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum. Reprod. Update 20, 76\u2013105 (2014). https:\/\/doi.org\/10.1093\/humupd\/dmt038.","journal-title":"Hum. Reprod. Update"},{"key":"4305_CR21","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"R.S. Legro, S.A. Arslanian, D.A. Ehrmann, K.M. Hoeger, M.H. Murad, R. Pasquali, C.K. Welt, Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 98, 4565\u20134592 (2013). https:\/\/doi.org\/10.1210\/jc.2013-2350.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4305_CR22","first-page":"65","volume":"44","author":"L Ruzi\u0107","year":"2003","unstructured":"L. Ruzi\u0107, B.R. Matkovi\u0107, G. Leko, Antiandrogens in hormonal contraception limit muscle strength gain in strength training: comparison study. Croat. Med. J. 44, 65\u201368 (2003).","journal-title":"Croat. Med. J."},{"key":"4305_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19\u201325 (2004). https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004.","journal-title":"Fertil. Steril."},{"key":"4305_CR24","doi-asserted-by":"publisher","first-page":"105776","DOI":"10.1016\/j.appet.2021.105776","volume":"168","author":"S Cetik","year":"2022","unstructured":"S. Cetik, A. Acikgoz, B.O. Yildiz, Investigation of taste function and eating behavior in women with polycystic ovary syndrome. Appetite 168, 105776 (2022). https:\/\/doi.org\/10.1016\/j.appet.2021.105776.","journal-title":"Appetite"},{"key":"4305_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"D. Lizneva, L. Suturina, W. Walker, S. Brakta, L. Gavrilova-Jordan, R. Azziz, Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 106, 6\u201315 (2016). https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003.","journal-title":"Fertil. Steril."},{"key":"4305_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"H.J. Teede, C.T. Tay, J.J.E. Laven, A. Dokras, L.J. Moran, T.T. Piltonen, M.F. Costello, J. Boivin, L.M. Redman, J.A. Boyle, R.J. Norman, A. Mousa, A.E. Joham, International PCOS Network., Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 120, 767\u2013793 (2023). https:\/\/doi.org\/10.1016\/j.fertnstert.2023.07.025.","journal-title":"Fertil. Steril."},{"key":"4305_CR27","doi-asserted-by":"publisher","first-page":"107982","DOI":"10.1016\/j.maturitas.2024.107982","volume":"185","author":"B \u00c7elik Ero\u011flu","year":"2024","unstructured":"B. \u00c7elik Ero\u011flu, L. Kara\u00e7oban, I.S. Id\u0131lman, F. Korkusuz, B.O. Y\u0131ld\u0131z, Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome. Maturitas 185, 107982 (2024). https:\/\/doi.org\/10.1016\/j.maturitas.2024.107982.","journal-title":"Maturitas"},{"key":"4305_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1590\/s0100-72032012000700005","volume":"34","author":"GS Kogure","year":"2012","unstructured":"G.S. Kogure, F.K. Piccki, C.S. Vieira, P. Martins Wde, R.M. dos Reis, [Analysis of muscle strength and body composition of women with polycystic ovary syndrome]. Rev. Bras. Ginecol. Obstet. 34, 316\u2013322 (2012). https:\/\/doi.org\/10.1590\/s0100-72032012000700005.","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"4305_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/09513590.2014.982083","volume":"31","author":"GS Kogure","year":"2015","unstructured":"G.S. Kogure, R.C. Silva, F.K. Picchi Ramos, C.L. Miranda-Furtado, L.A. Lara, R.A. Ferriani, R.M. Dos Reis, Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition. Gynecol. Endocrinol. 31, 237\u2013242 (2015). https:\/\/doi.org\/10.3109\/09513590.2014.982083.","journal-title":"Gynecol. Endocrinol."},{"key":"4305_CR30","doi-asserted-by":"publisher","first-page":"e13255","DOI":"10.1111\/obr.13255","volume":"22","author":"M Kazemi","year":"2021","unstructured":"M. Kazemi, R.A. Pierson, S.A. Parry, M. Kaviani, P.D. Chilibeck, Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: a systematic review and meta-analysis of 45 observational studies. Obes. Rev. 22, e13255 (2021). https:\/\/doi.org\/10.1111\/obr.13255.","journal-title":"Obes. Rev."},{"key":"4305_CR31","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/humrep\/deu096","volume":"29","author":"U Ezeh","year":"2014","unstructured":"U. Ezeh, M. Pall, R. Mathur, R. Azziz, Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Hum. Reprod. 29, 1508\u20131517 (2014). https:\/\/doi.org\/10.1093\/humrep\/deu096.","journal-title":"Hum. Reprod."},{"key":"4305_CR32","doi-asserted-by":"publisher","first-page":"e0292623","DOI":"10.1371\/journal.pone.0292623","volume":"18","author":"TM Fighera","year":"2023","unstructured":"T.M. Fighera, B.R. Dos Santos, P.M. Spritzer, Lean mass and associated factors in women with PCOS with different phenotypes. PLoS One 18, e0292623 (2023). https:\/\/doi.org\/10.1371\/journal.pone.0292623.","journal-title":"PLoS One"},{"key":"4305_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00404-019-05229-2","volume":"300","author":"E Caliskan Guzelce","year":"2019","unstructured":"E. Caliskan Guzelce, D. Eyupoglu, S. Torgutalp, F. Aktoz, O. Portakal, H. Demirel, B.O. Yildiz, Is muscle mechanical function altered in polycystic ovary syndrome?. Arch. Gynecol. Obstet. 300, 771\u2013776 (2019). https:\/\/doi.org\/10.1007\/s00404-019-05229-2.","journal-title":"Arch. Gynecol. Obstet."},{"key":"4305_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.contraception.2012.07.005","volume":"87","author":"K Aydin","year":"2013","unstructured":"K. Aydin, N. Cinar, D.Y. Aksoy, G. Bozdag, B.O. Yildiz, Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination. Contraception 87, 358\u2013362 (2013). https:\/\/doi.org\/10.1016\/j.contraception.2012.07.005.","journal-title":"Contraception"},{"key":"4305_CR35","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1210\/jc.2014-1135","volume":"99","author":"D Glintborg","year":"2014","unstructured":"D. Glintborg, M.L. Altinok, H. Mumm, A.P. Hermann, P. Ravn, M. Andersen, Body composition is improved during 12 months\u2019 treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 99, 2584\u20132591 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1135.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4305_CR36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/bjsports-2017-097582","volume":"51","author":"E Eklund","year":"2017","unstructured":"E. Eklund, B. Berglund, F. Labrie, K. Carlstr\u00f6m, L. Ekstr\u00f6m, A.L. Hirschberg, Serum androgen profile and physical performance in women olympic athletes. Br. J. Sports Med. 51, 1301\u20131308 (2017). https:\/\/doi.org\/10.1136\/bjsports-2017-097582.","journal-title":"Br. J. Sports Med."},{"key":"4305_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bjsm.2003.009886","volume":"39","author":"KJ Elliott","year":"2005","unstructured":"K.J. Elliott, N.T. Cable, T. Reilly, Does oral contraceptive use affect maximum force production in women?. Br. J. Sports Med. 39, 15\u201319 (2005). https:\/\/doi.org\/10.1136\/bjsm.2003.009886.","journal-title":"Br. J. Sports Med."},{"key":"4305_CR38","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1519\/JSC.0b013e31817ae1f3","volume":"22","author":"AW Nichols","year":"2008","unstructured":"A.W. Nichols, R.K. Hetzler, R.J. Villanueva, C.D. Stickley, I.F. Kimura, Effects of combination oral contraceptives on strength development in women athletes. J. Strength. Cond. Res. 22, 1625\u20131632 (2008). https:\/\/doi.org\/10.1519\/JSC.0b013e31817ae1f3.","journal-title":"J. Strength. Cond. Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04305-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:11:59Z","timestamp":1753369919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04305-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4305"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04305-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the ethical committee of Hacettepe University, Ankara, Turkey. The clinical examinations were conducted to the ethical principles outlined in the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}